Search Result |
Top |
| Entry | Name | Description | Category | Pathway | Gene |
|---|---|---|---|---|---|
| H00624 | Progressive familial intrahepatic cholestasis | Progressive familial intrahepatic cholestasis (PFIC) is a heterogeneous group of rare, genetic autosomal recessive disorders characterized by unremitting cholestasis and progression to liver failure. The ... | Inherited metabolic disorder |
(PFIC1) ATP8B1 [HSA:5205] [KO:K01530] (PFIC2) ABCB11 [HSA:8647] [KO:K05664] (PFIC3) ABCB4 [HSA:5244] [KO:K05659] (PFIC4) TJP2 [HSA:9414] [KO:K06098] (PFIC5) NR1H4 [HSA:9971] [KO:K08537] (PFIC6) SLC51A [HSA:200931] [KO:K14360] (PFIC7) USP53 [HSA:54532] (PFIC8) KIF12 [HSA:113220] [KO:K10399] (PFIC9) ZFYVE19 [HSA:84936] [KO:K24778] (PFIC10) MYO5B [HSA:4645] [KO:K10357] (PFIC11) SEMA7A [HSA:8482] [KO:K06529] (PFIC12) VPS33B [HSA:26276] [KO:K23281] |
|
| H01935 | Familial hypercholanemia | Familial hypercholanemia is characterized by elevated serum bile acid concentrations, itching, and fat malabsorption. Mutations in EPHX1, TJP2, and BAAT may disrupt bile acid transport and circulation. | Inherited metabolic disorder |
(FHCA1) TJP2 [HSA:9414] [KO:K06098] (FHCA1) BAAT [HSA:570] [KO:K00659] (FHCA2) SLC10A1 [HSA:6554] [KO:K14341] |
| [ KEGG | DISEASE | DRUG | MEDICUS ] |